Artificial Cornea and Corneal Implant Market Size Worth USD 1,022.67 Million by 2034 | CAGR: 7.3%

The artificial cornea and corneal implants market size is expected to reach USD  1,022.67  Million by 2034, according to a new study by Polaris Market Research. The report “Artificial Cornea and Corneal Implant Market Share, Size, Trends, Industry Analysis Report: By Type, By Transplant Type, By Disease Indication, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Artificial cornea and corneal implants are medical devices used to restore vision in patients with extensive corneal damage or disease. They replace classical corneal transplants and assist in enhancing vision and quality of life. Continuous advancements in biomaterials and surgical techniques are enhancing implant performance and patient outcomes.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/artificial-cornea-and-corneal-implant-market/request-for-sample

The market growth is driven by the rising prevalence of corneal disorders, increasing adoption of advanced implant technologies, growing awareness about vision restoration options, and expanding access to ophthalmic care worldwide.

Top of FormArtificial Cornea and Corneal Implant Market Report Highlights

• Based on implant type, the synthetic segment held the largest share due to its durability and lower rejection risk.
• Based on transplant type, the hard keratoprosthesis segment accounted for the largest market share in 2024 due to its effective treatment of severe corneal disorders.
• Based on disease indication, keratoconus segment witnessed steady growth due to growing diagnosis rates and enhanced availability of surgical procedures.
• Based on end user, hospitals segment accounted for the largest market share in 2024 driven by the availability of advanced surgical equipment and skilled ophthalmic surgeons.
• North America hold the largest share of the global artificial cornea and corneal implant market in 2024, fueled by strong healthcare infrastructure and high adoption of innovative ophthalmic technologies.
• Asia Pacific witnessed steady growth due to the rising elderly population and expanding healthcare access in emerging economies.
• A few global key market players include AJL Ophthalmic S.A., CorneaGen Inc., LinkoCare Life Sciences AB, Pantheon Vision, Addition Technology Inc., CorNeat Vision, Mediphacos, Aurolab, DIOPTEX GmbH, EyeYon Medical, Presbia plc, and Massachusetts Eye and Ear.

Polaris Market Research has segmented the market report on the basis of implant type, transplant type, disease indication, end user, and region:

By Implant Type Outlook (Revenue, USD Million, 2020–2034)

• Synthetic
• Biosynthetic

By Transplant Type Outlook (Revenue, USD Million, 2020–2034)

• Hard Keratoprosthesis
• Soft Keratoprosthesis

By Disease Indication (Revenue, USD Million, 2020–2034)

• Fuchs’ Dystrophy
• Keratoconus
• Fungal Keratitis
• Other Diseases

By End User Outlook (Revenue, USD Million, 2020–2034)

• Hospitals
• Opthalmic Centers

By Regional Outlook (Revenue, USD Million, 2020–2034)

• North America

• US
• Canada

• Europe

• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe

• Asia Pacific

• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific

• Middle East & Africa

• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa

• Latin America

• Mexico
• Brazil
• Argentina
• Rest of Latin America